Practice 9 structured short- and long-answer medical questions on Liver Tumors: Benign and Malignant Overview. Review model answers for exam revision.
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: This document provides a concise overview of both benign and malignant liver tumors. Benign tumors discussed include Cavernous Hemangioma, which is the most common and should not be biopsied due to hemorrhage risk; Focal Nodular Hyperplasia, characterized by a central stellate scar and lacking malignant potential; and Liver Cell Adenoma, which is linked to oral contraceptive use in young women and carries a significant risk of rupture. Malignant tumors are categorized into primary and secondary types. Primary malignancies include Hepatocellular Carcinoma (HCC), strongly associated with Hepatitis B and C infections, and elevated alpha-fetoprotein (AFP) levels; Cholangiocarcinoma, originating from bile ducts and notably *not* linked to viral hepatitis; Angiosarcoma, associated with specific toxic exposures; and Hepatoblastoma, primarily affecting children. Secondary liver malignancies (metastatic) are the most common hepatic malignancy overall, frequently originating from colon, lung, and breast cancers. ## Key Points - **Cavernous Hemangioma**: Most common benign liver tumor; DO NOT biopsy due to hemorrhage risk. - **Focal Nodular Hyperplasia (FNH)**: Characterized by a central stellate scar; no link to OCPs or malignant potential, no rupture risk. - **Liver Cell Adenoma**: Associated with young women and OCPs; significant risk of rupture leading to intraabdominal hemorrhage. - **Hepatocellular Carcinoma (HCC)**: Strongly linked to HBV (200x risk) and HCV; often presents with vascular invasion and AFP > 1000 ng/ml. Fibrolamellar variant has a better prognosis. - **Cholangiocarcinoma**: Bile duct origin; NOT associated with HBV/HCV, distinguishing it from HCC. - **Angiosarcoma**: Associated with exposure to vinyl chloride, arsenic, and Thorotrast. - **Hepatoblastoma**: Predominantly affects children. - **Secondary (Metastatic) Liver Tumors**: Most common hepatic malignancy overall, with primary sources typically being colon, lung, and breast. ## Detailed Notes ### Benign Tumors **Cavernous Hemangioma** - Most common benign liver tumor - Incidental finding - DO NOT biopsy (hemorrhage risk) **Focal Nodular Hyperplasia (FNH)** - Central stellate scar - No OCP link, no malignant potential, no rupture **Liver Cell Adenoma** - Young women + OCPs - Can rupture → intraabdominal hemorrhage - Can be mistaken for HCC - Regresses on stopping OCPs ### Malignant — Primary **Hepatocellular Carcinoma (HCC)** - M:F = 3:1 to 8:1 - Risk factors: HBV (200x risk), HCV, alcohol, aflatoxin B1, cirrhosis - Vascular invasion - AFP > 1000 ng/ml highly suggestive - Fibrolamellar variant = better prognosis - Px: death 6 months-1 year - Rx: surgical resection **Cholangiocarcinoma** - Bile duct origin - NOT associated with HBV/HCV - Risk factors: PSC, Opisthorchis sinensis, Thorotrast - AFP normal **Angiosarcoma** - Vinyl chloride + arsenic + Thorotrast **Hepatoblastoma** - Children ### Malignant — Secondary (Metastatic) - Most common hepatic malignancy overall - Sources: colon > lung > breast **Key comparison:** | | HCC | Cholangiocarcinoma | |---|---|---| | HBV/HCV | Yes | **No** | | AFP | ↑↑ | Normal | | Risk | Cirrhosis, aflatoxin | PSC, Opisthorchis | ## Practice Questions